ClinVar Miner

Submissions for variant NM_000179.3(MSH6):c.2673C>G (p.Ile891Met)

gnomAD frequency: 0.00001  dbSNP: rs146006741
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000215122 SCV000279264 uncertain significance not provided 2016-10-17 criteria provided, single submitter clinical testing This variant is denoted MSH6 c.2673C>G at the cDNA level, p.Ile891Met (I891M) at the protein level, and results in the change of an Isoleucine to a Methionine (ATC>ATG). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. MSH6 Ile891Met was not observed at a significant allele frequency in the NHLBI Exome Sequencing Project. Since Isoleucine and Methionine share similar properties, this is considered a conservative amino acid substitution. MSH6 Ile891Met occurs at a position where amino acids with properties similar to Isoleucine are tolerated across species and is located in MutS domain III (Terui 2013). In silico analyses are inconsistent regarding the effect this variant may have on protein structure and function. Based on currently available information, it is unclear whether MSH6 Ile891Met is pathogenic or benign. We consider it to be a variant of uncertain significance.
Invitae RCV000473265 SCV000551150 benign Hereditary nonpolyposis colorectal neoplasms 2023-10-15 criteria provided, single submitter clinical testing
Ambry Genetics RCV001016279 SCV001177217 uncertain significance Hereditary cancer-predisposing syndrome 2023-07-26 criteria provided, single submitter clinical testing The p.I891M variant (also known as c.2673C>G), located in coding exon 4 of the MSH6 gene, results from a C to G substitution at nucleotide position 2673. The isoleucine at codon 891 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
All of Us Research Program, National Institutes of Health RCV003998617 SCV004838460 uncertain significance Lynch syndrome 2023-08-08 criteria provided, single submitter clinical testing This missense variant replaces isoleucine with methionine at codon 891 of the MSH6 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with MSH6-related disorders in the literature. This variant has been identified in 2/250540 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.